Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Link-Asia International Medtech Group Ltd. ( (HK:1143) ) has provided an announcement.
Link-Asia International Medtech Group Ltd. has announced a proposal to privatise its subsidiary China Energy Storage Technology Development Ltd. through a scheme of arrangement in the Cayman Islands, under which all scheme shares will be cancelled in exchange for HK$0.45 per share in cash. Following completion of the transaction, the subsidiary’s shares will be delisted from the Hong Kong Stock Exchange, with new shares issued to the offeror to maintain share capital and a firm commitment that the cash consideration will not be increased, providing clarity for minority shareholders on exit terms and signalling a strategic shift away from the public market listing.
The scheme, initiated after a board resolution in late January 2026 and accepted by Fame Castle Enterprises Ltd. as offeror, will apply any reserve created from the share cancellation to fully pay up the new shares issued to the offeror at par value. The deal structure underscores the controlling shareholder’s intent to consolidate ownership and streamline capital structure, while the stated absence of planned dividends or capital returns before the effective date ensures that the announced HK$0.45 per share represents the definitive cash value for participating shareholders.
The most recent analyst rating on (HK:1143) stock is a Hold with a HK$0.38 price target. To see the full list of analyst forecasts on Link-Asia International Medtech Group Ltd. stock, see the HK:1143 Stock Forecast page.
More about Link-Asia International Medtech Group Ltd.
Link-Asia International Medtech Group Ltd., listed in Hong Kong, operates in the medical technology sector and is engaged in developing and supplying healthcare-related products and services across Asian markets. Its activities span medtech solutions that support clinical applications and health management, positioning the group to tap into growing regional demand for advanced medical technologies.
Average Trading Volume: 1,457,416
Technical Sentiment Signal: Sell
Current Market Cap: HK$87.47M
For a thorough assessment of 1143 stock, go to TipRanks’ Stock Analysis page.